187 related articles for article (PubMed ID: 6432610)
1. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
[TBL] [Abstract][Full Text] [Related]
2. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
[TBL] [Abstract][Full Text] [Related]
3. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
DeFronzo RA; Simonson DC
Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
[TBL] [Abstract][Full Text] [Related]
4. Effects of glyburide on in vivo insulin-mediated glucose disposal.
Simonson DC
Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
[TBL] [Abstract][Full Text] [Related]
5. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
[TBL] [Abstract][Full Text] [Related]
6. The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.
Kolterman OG; Gray RS; Shapiro G; Scarlett JA; Griffin J; Olefsky JM
Diabetes; 1984 Apr; 33(4):346-54. PubMed ID: 6423429
[TBL] [Abstract][Full Text] [Related]
7. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
9. Recovery of Staub Effect and amelioration of insulin secretion defects after glyburide treatment in non-insulin-dependent diabetes.
Soneru IL; Hein N; Jeffery JD; Abraira C
Diabetes Res; 1990 Oct; 15(2):77-83. PubMed ID: 2132401
[TBL] [Abstract][Full Text] [Related]
10. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM.
Jeng CY; Sheu WH; Fuh MM; Chen YD; Reaven GM
Diabetes; 1994 Dec; 43(12):1440-4. PubMed ID: 7958496
[TBL] [Abstract][Full Text] [Related]
11. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
12. How does glibenclamide lower plasma glucose concentration in patients with type 2 diabetes?
Jeng CY; Hollenbeck CB; Wu MS; Chen YD; Reaven GM
Diabet Med; 1989; 6(4):303-8. PubMed ID: 2524334
[TBL] [Abstract][Full Text] [Related]
13. Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis.
Mari A
Diabetologia; 1998 Sep; 41(9):1029-39. PubMed ID: 9754821
[TBL] [Abstract][Full Text] [Related]
14. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
Falko JM; Osei K
Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus.
Campbell PJ; Mandarino LJ; Gerich JE
Metabolism; 1988 Jan; 37(1):15-21. PubMed ID: 3275857
[TBL] [Abstract][Full Text] [Related]
16. Glyburide decreases insulin requirement, increases beta-cell response to mixed meal, and does not affect insulin sensitivity: effects of short- and long-term combined treatment in secondary failure to sulfonylurea.
Gutniak M; Karlander SG; Efendić S
Diabetes Care; 1987; 10(5):545-54. PubMed ID: 2890501
[TBL] [Abstract][Full Text] [Related]
17. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
[TBL] [Abstract][Full Text] [Related]
18. Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone.
Lardinois CK; Liu GC; Reaven GM
Arch Intern Med; 1985 Jun; 145(6):1028-32. PubMed ID: 3923961
[TBL] [Abstract][Full Text] [Related]
19. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.
DeFronzo RA; Ferrannini E; Simonson DC
Metabolism; 1989 Apr; 38(4):387-95. PubMed ID: 2657323
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy.
Nyomba BL; Freymond D; Raz I; Stone K; Mott DM; Bogardus C
Metabolism; 1990 Nov; 39(11):1204-10. PubMed ID: 2122177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
